<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37506491</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9157</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of autoimmunity</Title><ISOAbbreviation>J Autoimmun</ISOAbbreviation></Journal><ArticleTitle>Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.</ArticleTitle><Pagination><StartPage>103089</StartPage><MedlinePgn>103089</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaut.2023.103089</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-8411(23)00098-7</ELocationID><Abstract><AbstractText>Systemic Lupus Erythematosus (SLE) is a chronic, multisystem, inflammatory autoimmune disease that disproportionately affects women. Trends in SLE prevalence and clinical course differ by ancestry, with those of African American ancestry presenting with more active, severe and rapidly progressive disease than European Americans. Previous research established altered epigenetic signatures in SLE patients compared to controls. However, the contribution of aberrant DNA methylation (DNAm) to the risk of SLE by ancestry and differences among patients with SLE-associated Lupus Nephritis (LN) has not been well described. We evaluated the DNA methylomes of 87 individuals including 41 SLE patients, with and without LN, and 46 controls enrolled in an ancestry diverse, well-characterized cohort study of established SLE (41 SLE patients [20 SLE-LN+, 21 SLE-LN-] and 46 sex-, race- and age-matched controls; 55% African American, 45% European American). Participants were genotyped using the Infinium Global Diversity Array (GDA), and genetic ancestry was estimated using principal components. Genome-wide DNA methylation was initially measured using the Illumina MethylationEPIC 850K Beadchip array followed by methylation-specific qPCR to validate the methylation status at putative loci. Differentially Methylated Positions (DMP) were identified using a case-control approach adjusted for ancestry. We identified a total of 51 DMPs in CpGs among SLE patients compared to controls. Genes proximal to these CpGs were highly enriched for involvement in type I interferon signaling. DMPs among European American SLE patients with LN were similar to African American SLE patients with and without LN. Our findings were validated using an orthogonal, methyl-specific PCR for three SLE-associated DMPs near or proximal to MX1, USP18, and IFITM1. Our study confirms previous reports that DMPs in CpGs associated with SLE are enriched in type I interferon genes. However, we show that European American SLE patients with LN have similar DNAm patterns to African American SLE patients irrespective of LN, suggesting that aberrant DNAm alters activity of type I interferon pathway leading to more severe disease independent of ancestry.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>Jose E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Hemant K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Absher</LastName><ForeName>Devin M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Sara J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA. Electronic address: rmyers@hudsonalpha.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: elizabethbrown@uabmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR064820</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR073850</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Autoimmun</MedlineTA><NlmUniqueID>8812164</NlmUniqueID><ISSNLinking>0896-8411</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D043222">Ubiquitin Thiolesterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C485560">USP18 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579071">MX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C062010">leu-13 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="N">Lupus Nephritis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043222" MajorTopicYN="N">Ubiquitin Thiolesterase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ancestry</Keyword><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">Disparities</Keyword><Keyword MajorTopicYN="N">Genotyping</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37506491</ArticleId><ArticleId IdType="mid">NIHMS1921792</ArticleId><ArticleId IdType="pmc">PMC10529132</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2023.103089</ArticleId><ArticleId IdType="pii">S0896-8411(23)00098-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384:1878&#x2013;1888</Citation><ArticleIdList><ArticleId IdType="pubmed">24881804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Davidson A (2012) Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 18:871&#x2013;882</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607103</ArticleId><ArticleId IdType="pubmed">22674006</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC (2011) Systemic lupus erythematosus. The New England journal of medicine 365 22:2110&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM (1989) Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology. In: Advances in Immunology. Elsevier, pp 93&#x2013;151</Citation><ArticleIdList><ArticleId IdType="pubmed">2646863</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly PM, Parton H, Wang L, et al. (2021) Prevalence of Systemic Lupus Erythematosus in the United States: Estimates from a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol 73:991&#x2013;996</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169527</ArticleId><ArticleId IdType="pubmed">33474834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau CS, Yin G, Mok MY (2006) Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15:715&#x2013;719</Citation><ArticleIdList><ArticleId IdType="pubmed">17153840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez M, Alarc&#xf3;n GS, Calvo-al&#xe9;n J, Andrade R, McGwin G, Vil&#xe1; LM, Reveille JD, LUMINA Study Group (2007) A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 57:576&#x2013;584</Citation><ArticleIdList><ArticleId IdType="pubmed">17471524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar K, Chambers S, Gordon C (2009) Challenges of ethnicity in SLE. Best Practice &amp; Research Clinical Rheumatology 23:549&#x2013;561</Citation><ArticleIdList><ArticleId IdType="pubmed">19591784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MJ, Jawad AS (2016) The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology kew 399</Citation><ArticleIdList><ArticleId IdType="pubmed">27940583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastian HM, Roseman JM, Mcgwin G, Alarc&#xf3;n GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD, Lumina Study Group (2002) Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 11:152&#x2013;160</Citation><ArticleIdList><ArticleId IdType="pubmed">12004788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mccarty DJ, Manzi S, Medsger TA, Ramsey-Goldman R, Laporte RE, Kwoh CK (1995) Incidence of systemic lupus erythematosus race and gender differences. Arthritis &amp; Rheumatism 38:1260&#x2013;1270</Citation><ArticleIdList><ArticleId IdType="pubmed">7575721</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantinga LC, Lim SS, Patzer RE, McClellan WW, Kramer MR, Klein M, Pastan SO, Gordon C, Helmick CG, Drenkard C (2016) Incidence of End-Stage renal disease among newly diagnosed systemic lupus erythematosus patients: The georgia lupus registry. Arthritis Care &amp; Research 68:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4740266</ArticleId><ArticleId IdType="pubmed">26239749</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RR, Yen EY (2018) SLE mortality remains disproportionately high, despite improvements over the last decade. Lupus 27:1577&#x2013;1581</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6082727</ArticleId><ArticleId IdType="pubmed">30016928</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams JN, Drenkard C, Lim SS (2023) The impact of social determinants of health on the presentation, management and outcomes of systemic lupus erythematosus. Rheumatology (Oxford) 62:i10&#x2013;i14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10050938</ArticleId><ArticleId IdType="pubmed">36987604</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr RG, Seliger SL, Appel GB, Zuniga R, D&#x2019;Agati VD, Salmon J, Radhakrishnan J (2003) Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 18 10:2039&#x2013;46</Citation><ArticleIdList><ArticleId IdType="pubmed">13679478</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M (1991) Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. The American Journal of Medicine 91:345&#x2013;353</Citation><ArticleIdList><ArticleId IdType="pubmed">1951378</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen CP, Beggs ML, Saeed M, Walker PD (2013) Apolipoprotein L1 Risk Variants Associate with Systemic Lupus Erythematosus-Associated Collapsing Glomerulopathy. JASN 24:722&#x2013;725</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3636799</ArticleId><ArticleId IdType="pubmed">23520206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos PS, Oates JC, Kamen DL, et al. (2013) Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry. J Rheumatol 40:842&#x2013;849</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3735344</ArticleId><ArticleId IdType="pubmed">23637325</ArticleId></ArticleIdList></Reference><Reference><Citation>Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35:311&#x2013;318</Citation><ArticleIdList><ArticleId IdType="pubmed">1536669</ArticleId></ArticleIdList></Reference><Reference><Citation>Javierre BM, Fernandez AF, Richter J, et al. (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20:170&#x2013;179</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813473</ArticleId><ArticleId IdType="pubmed">20028698</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson BC, Ray D, Yung R (2004) Murine models of lupus induced by hypomethylated T cells. Methods in molecular medicine 102:285&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4023250</ArticleId><ArticleId IdType="pubmed">15286391</ArticleId></ArticleIdList></Reference><Reference><Citation>Absher DM, Li X, Waite LL, Gibson A, Roberts K, Edberg J, Chatham WW, Kimberly RP (2013) Genome-Wide DNA Methylation Analysis of Systemic Lupus Erythematosus Reveals Persistent Hypomethylation of Interferon Genes and Compositional Changes to CD4+ T-cell Populations. PLoS Genet 9:e1003678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738443</ArticleId><ArticleId IdType="pubmed">23950730</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n GS, Mcgwin GJ, Petri MA, Reveille JD, Ramsey-Goldman R, Kimberly RP (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:101&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pubmed">11958584</ArticleId></ArticleIdList></Reference><Reference><Citation>VanValkenburg ME, Pruitt GI, Brill IK, et al. (2015) Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features. Cancer Causes &amp; Control 27:81&#x2013;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703620</ArticleId><ArticleId IdType="pubmed">26596855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis &amp; Rheumatism 40:1725&#x2013;1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai A-M, Alarc&#xf3;n GS, et al. (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis &amp; Rheumatism 64:2677&#x2013;2686</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Danecek P, Bonfield JK, Liddle J, et al. (2021) Twelve years of SAMtools and BCFtools. GigaScience 10:giab008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931819</ArticleId><ArticleId IdType="pubmed">33590861</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks JP (2010) plink: An R package for linking mixed-format tests using IRT-Based methods. Journal of Statistical Software 35:1&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairley S, Lowy-Gallego E, Perry E, Flicek P (2020) The International Genome Sample Resource (IGSR) collection of open human genomic variation resources. Nucleic Acids Research 48:D941&#x2013;D947</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943028</ArticleId><ArticleId IdType="pubmed">31584097</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Forer L, Sch&#xf6;nherr S, et al. (2016) Next-generation genotype imputation service and methods. Nature Genetics 48:1284&#x2013;1287</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5157836</ArticleId><ArticleId IdType="pubmed">27571263</ArticleId></ArticleIdList></Reference><Reference><Citation>Browning SR, Browning BL (2007) Rapid and Accurate Haplotype Phasing and Missing-Data Inference for Whole-Genome Association Studies By Use of Localized Haplotype Clustering. The American Journal of Human Genetics 81:1084&#x2013;1097</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265661</ArticleId><ArticleId IdType="pubmed">17924348</ArticleId></ArticleIdList></Reference><Reference><Citation>Maples BK, Gravel S, Kenny EE, Bustamante CD (2013) RFMix: A Discriminative Modeling Approach for Rapid and Robust Local-Ancestry Inference. The American Journal of Human Genetics 93:278&#x2013;288</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738819</ArticleId><ArticleId IdType="pubmed">23910464</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander DH, Novembre J, Lange K (2009) Fast model-based estimation of ancestry in unrelated individuals. Genome Res 19:1655&#x2013;1664</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752134</ArticleId><ArticleId IdType="pubmed">19648217</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team (2022) R: A language and environment for statistical computing.</Citation></Reference><Reference><Citation>Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA (2014) Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30:1363&#x2013;1369</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4016708</ArticleId><ArticleId IdType="pubmed">24478339</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen C, Castillo-Fernandez JE, Domingo-Relloso A, et al. (2021) Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects. Clin Epigenet 13:36</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7888173</ArticleId><ArticleId IdType="pubmed">33593402</ArticleId></ArticleIdList></Reference><Reference><Citation>Du P, Zhang X, Huang C-C, Jafari N, Kibbe WA, Hou L, Lin SM (2010) Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11:587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3012676</ArticleId><ArticleId IdType="pubmed">21118553</ArticleId></ArticleIdList></Reference><Reference><Citation>Houseman EA, Kile ML, Christiani DC, Ince TA, Kelsey KT, Marsit CJ (2016) Reference-free deconvolution of DNA methylation data and mediation by cell composition effects. BMC Bioinformatics 17:259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928286</ArticleId><ArticleId IdType="pubmed">27358049</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, Beck S (2014) ChAMP: 450k Chip Analysis Methylation Pipeline. Bioinformatics 30:428&#x2013;430</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3904520</ArticleId><ArticleId IdType="pubmed">24336642</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavent M, Kuentz-Simonet V, Labenne A, Saracco J (2014) Multivariate analysis of mixed data: The R package PCAmixdata. arXiv: Computation</Citation></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D-L, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43:e47&#x2013;e47</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharer CD, Blalock EL, Mi T, et al. (2019) Epigenetic programming underpins B cell dysfunction in human SLE. Nat Immunol 20:1071&#x2013;1082</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642679</ArticleId><ArticleId IdType="pubmed">31263277</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitbach ME, Ramaker RC, Roberts K, Kimberly RP, Absher D (2020) Population-Specific Patterns of Epigenetic Defects in the B Cell Lineage in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol 72:282&#x2013;291</Citation><ArticleIdList><ArticleId IdType="pubmed">31430064</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Jeffries MA, Altorok N, Dozmorov MG, Koelsch KA, Wren JD, Merrill JT, Mccune WJ, Sawalha AH (2013) Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in na&#xef;ve CD4+ T cells from lupus patients. Journal of autoimmunity 43:78&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3790645</ArticleId><ArticleId IdType="pubmed">23623029</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph S, George NI, Green-knox B, Treadwell EL, Word B, Yim S, Lyn-cook B (2019) Epigenome-wide association study of peripheral blood mononuclear cells in systemic lupus erythematosus: Identifying DNA methylation signatures associated with interferon-related genes based on ethnicity and SLEDAI. Journal of Autoimmunity 96:147&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pubmed">30301579</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Ortiz-Fernandez L, Lewis EE, McCune WJ, Maksimowicz-McKinnon K, Sawalha AH (2020) A longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patients. JCI Insight 5:e143654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7710270</ArticleId><ArticleId IdType="pubmed">33108347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulff-M&#xf8;ller CJ, Asmar F, Liu Y, Svendsen AJ, Busato F, Gr&#xf8;nbaek K, Tost J, Jacobsen S (2018) Twin DNA Methylation Profiling Reveals Flare-Dependent Interferon Signature and B Cell Promoter Hypermethylation in Systemic Lupus Erythematosus. Arthritis Rheumatol 70:878&#x2013;890</Citation><ArticleIdList><ArticleId IdType="pubmed">29361205</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KE, Remmers EF, Lee AT, et al. (2008) Specificity of the STAT4 Genetic Association for Severe Disease Manifestations of Systemic Lupus Erythematosus. PLoS Genet 4:e1000084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2377340</ArticleId><ArticleId IdType="pubmed">18516230</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Q, Thieu VT, Kaplan MH (2007) Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18R&#x3b1; gene during Th1 differentiation. EMBO J 26:2052&#x2013;2060</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1852779</ArticleId><ArticleId IdType="pubmed">17380127</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi KZ, Wilhelm TR, Ulff-M&#xf8;ller CJ, Jacobsen S (2021) Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies.: Expression of interferon stimulated genes in systemic lupus. Translational research&#x202f;: the journal of laboratory and clinical medicine</Citation><ArticleIdList><ArticleId IdType="pubmed">34343626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiechmann T, R&#xf6;h S, Sauer S, et al. (2019) Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus. Clinical Epigenetics 11:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6533766</ArticleId><ArticleId IdType="pubmed">31122292</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosterom N, Griffioen PH, den Hoed MAH, Pieters R, de Jonge R, Tissing WJE, n den Heuvel-Eibrink MMM, Heil SG (2018) Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. PLoS ONE 13:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6037363</ArticleId><ArticleId IdType="pubmed">29985926</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Tang Q, Zhao M, et al. (2015) The effect of mycophenolic acid on epigenetic modifications in lupus CD4+T cells. Clinical immunology 158 1:67&#x2013;76</Citation><ArticleIdList><ArticleId IdType="pubmed">25791245</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PA, Taylor SM (1980) Cellular differentiation, cytidine analogs and DNA methylation. Cell 20:85&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">6156004</ArticleId></ArticleIdList></Reference><Reference><Citation>Suthanthiran M, Morris RE, Strom TB (1996) Immunosuppressants: Cellular and molecular mechanisms of action. American Journal of Kidney Diseases 28:159&#x2013;172</Citation><ArticleIdList><ArticleId IdType="pubmed">8768909</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>